HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hideki Mochizuki Selected Research

Intracranial Embolism

1/2022An Older Thrombus Delays Reperfusion after Mechanical Thrombectomy for Ischemic Stroke.
6/2017Recurrent Stroke Due to Metastatic Pulmonary Tumor Emboli as an Important Clinical Entity.
1/2013Relationship between plasma (D)-dimer level and cerebral infarction volume in patients with nonvalvular atrial fibrillation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Hideki Mochizuki Research Topics

Disease

77Parkinson Disease (Parkinson's Disease)
10/2022 - 06/2003
21Stroke (Strokes)
01/2022 - 02/2006
17Ischemic Stroke
09/2022 - 04/2016
16Neurodegenerative Diseases (Neurodegenerative Disease)
10/2022 - 07/2005
14Neoplasms (Cancer)
08/2020 - 07/2004
12Dementia (Dementias)
05/2022 - 10/2004
12Dyskinesias (Dyskinesia)
05/2022 - 07/2009
10Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease)
03/2022 - 03/2012
10Inflammation (Inflammations)
01/2022 - 11/2012
10Multiple Sclerosis
08/2021 - 04/2011
9Amyloidosis
01/2022 - 11/2008
7Alzheimer Disease (Alzheimer's Disease)
04/2022 - 02/2002
7Myotonic Dystrophy (Dystrophia Myotonica)
01/2022 - 01/2014
7Ischemia
01/2019 - 03/2002
6Mitochondrial Diseases (Mitochondrial Disease)
02/2022 - 02/2004
6Disease Progression
01/2022 - 01/2012
6Synucleinopathies
01/2019 - 10/2004
6Brain Ischemia (Cerebral Ischemia)
01/2018 - 03/2006
5Neuromyelitis Optica (Devic's Disease)
01/2022 - 01/2018
5Infarction (Infarctions)
12/2021 - 01/2013
5Glaucoma
11/2021 - 05/2010
5Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental)
01/2021 - 04/2011
5Parkinsonian Disorders (Parkinsonism)
01/2018 - 11/2010
4Muscular Diseases (Myopathy)
12/2022 - 01/2018
4Thrombosis (Thrombus)
09/2022 - 01/2013
4Infections
09/2022 - 10/2004
4Pain (Aches)
05/2022 - 01/2010
4Myasthenia Gravis
04/2022 - 01/2016
4Prostatic Neoplasms (Prostate Cancer)
01/2019 - 07/2004
4Neuroblastoma
01/2017 - 01/2013
4Myotonia
10/2016 - 06/2012
3Huntington Disease (Huntington's Disease)
01/2022 - 04/2008
3Intracranial Embolism
01/2022 - 01/2013
3Neuralgia (Stump Neuralgia)
08/2021 - 01/2019
3Hypersensitivity (Allergy)
01/2021 - 05/2010
3Multiple System Atrophy
01/2019 - 01/2010
3Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome)
12/2018 - 12/2016
3Hypertension (High Blood Pressure)
11/2018 - 04/2014
3Encephalitis (Encephalitis, Rasmussen)
01/2011 - 04/2010
3Anti-N-Methyl-D-Aspartate Receptor Encephalitis
01/2011 - 04/2010
3Reperfusion Injury
10/2010 - 04/2004
3Sleepiness
03/2008 - 12/2002
2Dystonia (Limb Dystonia)
05/2022 - 10/2020

Drug/Important Bio-Agent (IBA)

25SynucleinsIBA
10/2022 - 04/2008
23Proteins (Proteins, Gene)FDA Link
11/2022 - 07/2004
13Amyloid (Amyloid Fibrils)IBA
04/2022 - 01/2013
12Levodopa (L Dopa)FDA LinkGeneric
05/2022 - 01/2009
10Pharmaceutical PreparationsIBA
10/2022 - 03/2008
10AntibodiesIBA
01/2022 - 04/2010
10alpha-SynucleinIBA
01/2021 - 10/2004
7IronIBA
10/2021 - 12/2012
71- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)IBA
01/2021 - 02/2004
7Dopamine (Intropin)FDA LinkGeneric
10/2019 - 06/2003
6Peptides (Polypeptides)IBA
01/2022 - 11/2016
5Biomarkers (Surrogate Marker)IBA
03/2022 - 07/2019
5rasagiline (Azilect)FDA Link
01/2022 - 01/2018
5Phosphotransferases (Kinase)IBA
10/2021 - 08/2005
5fibrin fragment D (D-dimer)IBA
08/2020 - 01/2013
5Neuroprotective AgentsIBA
01/2019 - 03/2006
5UbiquitinIBA
08/2011 - 01/2006
4RNA (Ribonucleic Acid)IBA
01/2022 - 01/2016
4AutoantibodiesIBA
01/2022 - 06/2020
4EnzymesIBA
01/2022 - 05/2006
4Therapeutic UsesIBA
01/2021 - 02/2014
4Messenger RNA (mRNA)IBA
11/2020 - 01/2017
4C-Reactive ProteinIBA
08/2020 - 02/2013
4Toll-Like Receptors (Toll-Like Receptor)IBA
04/2020 - 11/2016
4CytokinesIBA
01/2018 - 03/2006
4Granulocyte Colony-Stimulating Factor (G-CSF)IBA
04/2014 - 03/2006
3Heparin (Liquaemin)FDA LinkGeneric
09/2022 - 02/2006
3Immunoglobulin G (IgG)IBA
06/2022 - 01/2018
3DNA-Binding Proteins (DNA Binding Protein)IBA
03/2022 - 08/2021
3neuromelaninIBA
02/2022 - 06/2018
3Dopamine Plasma Membrane Transport Proteins (Dopamine Transporter)IBA
02/2022 - 07/2019
3Reactive Oxygen Species (Oxygen Radicals)IBA
01/2022 - 08/2008
3AntigensIBA
01/2021 - 04/2010
3LigandsIBA
04/2020 - 07/2004
3Glutamic Acid (Glutamate)FDA Link
01/2019 - 04/2010
3Hormones (Hormone)IBA
01/2019 - 07/2008
3Epoprostenol (Prostacyclin)FDA LinkGeneric
01/2019 - 11/2007
3Monoamine Oxidase (MAO)IBA
01/2019 - 01/2019
3Apolipoproteins E (ApoE)IBA
01/2016 - 03/2014
3N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA
01/2012 - 10/2010
3Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
06/2010 - 03/2006
3Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
08/2007 - 03/2003
2Carbidopa (Lodosyn)FDA LinkGeneric
05/2022 - 09/2018
2Intravenous Immunoglobulins (IVIG)FDA Link
04/2022 - 01/2011
2Adrenal Cortex Hormones (Corticosteroids)IBA
04/2022 - 10/2020
2RNA-Binding Proteins (RNA-Binding Protein)IBA
03/2022 - 01/2020
2MicroRNAs (MicroRNA)IBA
02/2022 - 12/2021
2Fibrinolytic Agents (Antithrombotic Agents)IBA
02/2022 - 08/2020

Therapy/Procedure

29Therapeutics
01/2022 - 07/2005
5Activities of Daily Living (ADL)
05/2022 - 01/2014
5Drug Therapy (Chemotherapy)
01/2022 - 04/2016
4Electrodes (Electrode)
09/2017 - 09/2011
4Oral Administration
01/2016 - 12/2002
3Artificial Respiration (Mechanical Ventilation)
09/2022 - 01/2011
3Thrombectomy
01/2022 - 11/2020
3Nephrectomy
12/2018 - 07/2005
3Trabeculectomy (Trabeculoplasty)
11/2015 - 05/2010